Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid

dc.contributor.authorLara Gallego, Beatriz
dc.contributor.authorMartínez, María Teresa
dc.contributor.authorBlanco, Ignacio
dc.contributor.authorHernández, Cristina
dc.contributor.authorVelasco, Eladio
dc.contributor.authorFerrarotti, Ilaria
dc.contributor.authorRodríguez, Francisco
dc.contributor.authorPerez, Laura
dc.contributor.authorVazquez, Irene
dc.contributor.authorAlonso, Javier
dc.contributor.authorPosada, Manuel
dc.contributor.authorMartínez-Delgado, Beatriz
dc.description.abstract[Background]: Severe Alpha-1 Antitrypsin (AAT) deficiency is a hereditary condition caused by mutations in the SERPINA1 gene, which predisposes to lung emphysema and liver disease. It is usually related to PI*Z alleles, and less frequent to rare and null (QO) alleles. Null-AAT alleles represent the end of a continuum of variants associated with profound AAT deficiency and extremely increased risk of emphysema. [Methods]: A family with severe AAT deficiency was analyzed to achieve genetic diagnosis. The complete exons and introns of the SERPINA1 gene were sequenced and transcriptional analysis by RT-PCR was performed to characterize the effect of splicing variants found in the patients. In addition, a minigene MGserpa1_ex1b-1c was cloned into the pSAD vector to in vitro investigate the independent impact of variants on splicing process. [Results]: We report a new identified null allele (PI*QOMadrid) in two adult siblings with practically no detectable serum AAT. The PI*QOMadrid allele consist of a duplication of the thymine (T) in position +2 of the donor splice site of exon 1C (+2dupT). In these two subjects, PI*QOMadrid occurred in compound heterozygote combination with the previously described variant PI*QOPorto. Both QOMadrid and QOPorto variants are located very close together in a regulatory region of the SERPINA1 gene. Analysis of transcripts revealed that QOMadrid variant prevented the expression of transcripts from exon 1C, and then normally spliced RNA products are not expected in the liver of these patients. In addition, aberrant splicing patterns of both variants were clearly distinguished and quantified by functional in vitro assays lending further support to their pathogenicity. [Conclusion]: Finding pathogenic mutations in non-coding regions of the SERPINA1 highlight the importance that regulatory regions might have in the disease. Regulatory regions should be seriously considered in discordant cases with severe AAT deficiency where no coding mutations were found.ca_ES
dc.description.sponsorshipThis work has been partially funded by the Instituto de Salud Carlos III grants TPY1250/12 (BMD) and PI13/1749 (EAV) (Spanish Ministry of Economy and Competitiveness) and BIO/VA08/13 (Consejería de Sanidad, Junta de Castilla y León). CHM was supported by a fellowship from Fundación Villalar (Cortes de Castilla y León, Spain). We thank collaborators from the REDAAT (Spanish Registry of Alpha-1 Antitrypsin deficiency patients) and all members of the Human Genetics Area of the ISCIII for their support.ca_ES
dc.publisherBioMed Centralca_ES
dc.relation.isformatofReproducció del document publicat a
dc.relation.ispartofRespiratory Research, 2014, vol. 15, art. 125ca_ES
dc.rightscc-by (c) Beatriz Lara et al., 2015ca_ES
dc.subjectAlpha-1 antitrypsinca_ES
dc.subjectAllelic variantsca_ES
dc.subjectNull allelesca_ES
dc.subjectQO allelesca_ES
dc.titleSevere alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadridca_ES
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
1.47 MB
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
1.71 KB
Item-specific license agreed upon to submission